$44.00Average Price Target
The highest estimate is 63.00.
From 6 ratings within the last 6 months. This is not an investment recommendation.
This list is based on the watchlists of people on Stock Events who follow SION. It's not an investment recommendation.
This list is an analysis based on recent market events. It's not an investment recommendation.
Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefits to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.
FAQs
What is Sionna Therapeutics stock price today?▼
The current price of SION is $3.87 USD — it has decreased by -3.25% in the past 24 hours. Watch Sionna Therapeutics stock price performance more closely on the chart.
What is Sionna Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Sionna Therapeutics stocks are traded under the ticker SION.
Is Sionna Therapeutics stock price growing?▼
SION stock has risen by +4.88% compared to the previous week, the month change is a -21.18% fall, over the last year Sionna Therapeutics has showed a -89.87% decrease.
What is Sionna Therapeutics market cap?▼
Today Sionna Therapeutics has the market capitalization of 174.97M
When is the next Sionna Therapeutics earnings date?▼
Sionna Therapeutics is going to release the next earnings report on November 11, 2026.
What were Sionna Therapeutics earnings last quarter?▼
SION earnings for the last quarter are -0.66 USD per share, whereas the estimation was -0.65 USD resulting in a -1.54% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Sionna Therapeutics revenue for the last year?▼
Sionna Therapeutics revenue for the last year amounts to 0 USD.
What is Sionna Therapeutics net income for the last year?▼
SION net income for the last year is -75.27M USD.
How many employees does Sionna Therapeutics have?▼
As of November 2, 2026, the company has 59 employees.
In which sector is Sionna Therapeutics located?▼
Sionna Therapeutics operates in the Health & Wellness sector.
When did Sionna Therapeutics complete a stock split?▼
Sionna Therapeutics has not had any recent stock splits.
Where is Sionna Therapeutics headquartered?▼
Sionna Therapeutics is headquartered in WALTHAM, United States.